HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effect of triple antiretroviral therapy on Tunisian AIDS profile: study of 139 cases].

Abstract
We report a retrospective study to estimate highly active antiretroviral therapy (HAART) effect in 139 HIV infected patients. Four criteria are studied: prevalence of opportunistic infections, CD4 cell count evolution, viral load progression and mortality. Gastrointestinal side effects are the most common clinical adverse reaction (61.1 percent), and hematological side effects are the most common biological adverse reaction (61.2 percent). During the 22.8 months (3 months to 6 years) follow-up average period, CD4 cell counts remained above 500 per cubic millimeter in only 25.8 percent of cases, while 63.5 percent of patients had a viral load below 400 copies per milliliter. During the study on patients receiving HAART, opportunistic infections appeared in 17.3 percent of cases (24 cases) and mortality in 6.4 percent of cases.
AuthorsFayçal Zouiten, Lamia Ammari, Ahmed Goubantini, Hanène Tiouiri, Amine Slim, Ahmed Maamouri, Badreddine Kilani, Fakher Kanoun, Chekib Marrakchi, Nahed Neifer, Leila Mihoub, Faouzi Jenhani, Mounira Garbouj, Taoufik Ben Chaabane
JournalLa Tunisie medicale (Tunis Med) Vol. 81 Issue 12 Pg. 956-62 (Dec 2003) ISSN: 0041-4131 [Print] Tunisia
Vernacular TitleImpact de la trithérapie anti-retrovirale sur le profil evolutif du sideen Tunisien: etude de 139 cas.
PMID14986532 (Publication Type: English Abstract, Journal Article)
Topics
  • AIDS-Related Opportunistic Infections (epidemiology)
  • Acquired Immunodeficiency Syndrome (complications, drug therapy)
  • Adolescent
  • Adult
  • Aged
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Child
  • Disease Progression
  • Female
  • Humans
  • Incidence
  • Infant
  • Male
  • Middle Aged
  • Retrospective Studies
  • Tunisia
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: